Skip to main content
PAINWeek 2026 Main banner

Pharmacological and Opioid Management

POM-02 - Precision Pain Management: Genetic Profiling, Biomarkers, and Personalized Dosing Strategies

Tuesday, September 8, 2026
11:00 AM - 11:50 AM PDT
As precision medicine evolves, pain management is entering a new era of individualized care. This session explores how genetic profiling, pharmacogenomics, and biomarker-guided treatment selection can optimize therapy for both acute and chronic pain populations. Presenters will review how metabolic variants influence opioid effectiveness and safety, how biomarkers can differentiate neuropathic from nociceptive pain, and how pharmacists and prescribers can integrate personalized dosing algorithms into clinical practice. Practical case examples will illustrate how precision‑guided decisions improve outcomes, reduce adverse events, and enhance patient‑centered care.

Learning Objectives:

  • Discuss the role of genetic profiling, pharmacogenomics, and biomarker-guided treatment selection in optimizing pain management for acute and chronic pain populations.
  • Analyze the impact of metabolic variants on opioid effectiveness and safety to enhance individualized therapy.
  • Describe how biomarkers can differentiate neuropathic pain from nociceptive pain and guide targeted treatment strategies.
  • Apply personalized dosing algorithms and precision-guided decisions in clinical practice to improve outcomes, reduce adverse events, and enhance patient-centered care.
  • Distinguish between pharmacogenomics and biomarker‑guided approaches and describe how each contributes to precision pain management.